Search results
Results From The WOW.Com Content Network
The 340B Drug Pricing Program is a US federal government program created in 1992 that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The intent of the program is to allow covered entities to "stretch scarce federal resources as far as possible ...
The Program is a federal program. The 340B Drug Pricing Program, administered by the Office of Pharmacy Affairs, resulted from enactment of Public Law 102-585, the Veterans Health Care Act of 1992, which is codified as Section 340B of the Public Health Service Act.
One of the following programs is the 340B pricing program that allows hospitals and pharmacists to buy drugs at 30–50% off the retail prices. [71] Per HRSA's 340B Drug Pricing Program, drug manufacturers are required to give certain organizations discounted drugs given these organizations fit the eligibility criteria for discounts. [72]
HRSA rejected Lilly's cash replenishment model for reimbursing entities covered by the 340B Drug Pricing Program. This federal program provides prescription medications at lower costs to eligible ...
We cannot expand the 340B Program until we can be sure that the program is working to improve health-care access and health equity in New York.
For premium support please call: 800-290-4726 more ways to reach us
HRSA oversees a drug discount program for certain safety-net health care providers. [10] HRSA also supports the nation's poison control centers and vaccine injury compensation programs, which distribute awards to individuals and families who have been injured by certain vaccines, after proving it to the National Vaccine Injury Compensation ...
Pages in category "Drug pricing" ... 340B Drug Pricing Program; A. Access to medicines; Average wholesale price; C. Consumer import of prescription drugs; Cost of ...